Sign in
4

Changes in Ownership

NEUROCRINE BIOSCIENCES INC Filed Acc 0001209191-23-025763

Chief Medical Officer sold 14,400 shares at $103.48 ($1,490,059)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROBERTS EIRY · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-04-24 Sale : show line 1 in the form 10b5-1 −14,400 $103.48 $1,490,059 26,644 D
Open-market sales · 14,400 sh · avg $103.48 · $1,490,059
Loading xslF345X04/doc4.xml…